Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Abrams

Showing results (241-250 of 367) with videos related to

Pageof 37
Sort By:
Canine Genetics and Epidemiology|December 24, 2019
Pedigree analysis of atrial fibrillation in Irish wolfhounds supports a high heritability with a dominant mode of inheritanceSamantha L Fousse, William D Tyrrell, Mariellen E Dentino, et al.
European Journal of Biochemistry|March 15, 1989
A new crystal form of ricin-ORW R Chang, L Q Chen, J Rose, et al.
Veterinary Pathology|November 1, 1989
Canine bilateral extraocular polymyositisJ L Carpenter, G M Schmidt, F M Moore, et al.
Advances in Biological Regulation|October 15, 2022
Effects of chloroquine and hydroxychloroquine on the sensitivity of pancreatic cancer cells to targeted therapiesJames A McCubrey, Stephen L Abrams, Matilde Y Follo, et al.
British Journal of Clinical Pharmacology|April 10, 2016
The therapeutic potential of mTOR inhibitors in breast cancerLinda S Steelman, Alberto M Martelli, Lucio Cocco, et al.
Kidney International|February 1, 1989
1,25(OH)2D3 administration in moderate renal failure: a prospective double-blind trialL R Baker, L Abrams, C J Roe, et al.
Infection and Immunity|September 1, 1995
Enteral human serum immunoglobulin treatment of cryptosporidiosis in mice with severe combined immunodeficiencyT L Kuhls, S L Orlicek, D A Mosier, et al.
Journal of Strength and Conditioning Research|February 11, 2010
Supervised moderate intensity resistance exercise training improves strength in Special Olympic athletesTiffany R Tamse, Mark D Tillman, Christine B Stopka, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|June 12, 2020
GSK-3 and miRs: Master regulators of therapeutic sensitivity of cancer cellsPrzemysław Duda, Shaw M Akula, Stephen L Abrams, et al.
Cell Cycle (Georgetown, Tex.)|November 29, 2012
p53 expression controls prostate cancer sensitivity to chemotherapy and the MDM2 inhibitor Nutlin-3William H Chappell, Brian D Lehmann, David M Terrian, et al.
Pageof 37

Showing results (241-250 of 367) with videos related to

Sort By:
Pageof 37
Canine Genetics and Epidemiology|December 24, 2019
Pedigree analysis of atrial fibrillation in Irish wolfhounds supports a high heritability with a dominant mode of inheritanceSamantha L Fousse, William D Tyrrell, Mariellen E Dentino, et al.
European Journal of Biochemistry|March 15, 1989
A new crystal form of ricin-ORW R Chang, L Q Chen, J Rose, et al.
Veterinary Pathology|November 1, 1989
Canine bilateral extraocular polymyositisJ L Carpenter, G M Schmidt, F M Moore, et al.
Advances in Biological Regulation|October 15, 2022
Effects of chloroquine and hydroxychloroquine on the sensitivity of pancreatic cancer cells to targeted therapiesJames A McCubrey, Stephen L Abrams, Matilde Y Follo, et al.
British Journal of Clinical Pharmacology|April 10, 2016
The therapeutic potential of mTOR inhibitors in breast cancerLinda S Steelman, Alberto M Martelli, Lucio Cocco, et al.
Kidney International|February 1, 1989
1,25(OH)2D3 administration in moderate renal failure: a prospective double-blind trialL R Baker, L Abrams, C J Roe, et al.
Infection and Immunity|September 1, 1995
Enteral human serum immunoglobulin treatment of cryptosporidiosis in mice with severe combined immunodeficiencyT L Kuhls, S L Orlicek, D A Mosier, et al.
Journal of Strength and Conditioning Research|February 11, 2010
Supervised moderate intensity resistance exercise training improves strength in Special Olympic athletesTiffany R Tamse, Mark D Tillman, Christine B Stopka, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|June 12, 2020
GSK-3 and miRs: Master regulators of therapeutic sensitivity of cancer cellsPrzemysław Duda, Shaw M Akula, Stephen L Abrams, et al.
Cell Cycle (Georgetown, Tex.)|November 29, 2012
p53 expression controls prostate cancer sensitivity to chemotherapy and the MDM2 inhibitor Nutlin-3William H Chappell, Brian D Lehmann, David M Terrian, et al.
Pageof 37